Disease Overview：Ventricular tachycardia（VT）
Ventricular tachycardia (VT) is a potentially life-threatening cardiac arrhythmia characterized by three or more consecutive ventricular beats at a rate exceeding 100 beats per minute. Originating from the ventricles—rather than the sinoatrial node—VT disrupts normal electrical conduction, impairing cardiac output and increasing risk of hemodynamic instability, syncope, or sudden cardiac death. Etiologies include structural heart disease (e.g., prior myocardial infarction, cardiomyopathy), genetic channelopathies (e.g., long QT syndrome, Brugada syndrome), or idiopathic causes. Diagnosis relies on 12-lead ECG, Holter monitoring, electrophysiological study (EPS), and advanced imaging such as cardiac MRI to assess substrate. Management encompasses acute interventions (e.g., synchronized cardioversion, antiarrhythmic agents like amiodarone or lidocaine) and long-term strategies—including catheter ablation (particularly substrate-based or pace-mapping guided), implantable cardioverter-defibrillator (ICD) placement, and pharmacotherapy.
China offers distinct advantages for VT treatment: its leading cardiovascular centers—such as Fu Wai Hospital and Shanghai Ruijin Hospital—boast internationally trained electrophysiologists with extensive experience in complex ablation procedures, including high-density mapping and cryoablation. State-of-the-art infrastructure includes 3D electroanatomic mapping systems (CARTO, EnSite), intracardiac echocardiography, and robotic navigation platforms. Clinical outcomes align with global benchmarks: published data show >85% acute procedural success and <10% 1-year recurrence for ischemic and non-ischemic VT ablation. Crucially, costs are typically 40–60% lower than in the US or Western Europe—without compromising quality—due to streamlined healthcare financing and economies of scale. As a dedicated medical tourism agency, we facilitate seamless international care: verifying physician credentials, coordinating appointments at JCI-accredited hospitals, providing itemized, transparent pricing in advance, arranging visa support, interpreters, and post-procedure follow-up—all tailored to individual clinical and logistical needs.
Ventricular tachycardia: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Ventricular Tachycardia (Cardiology Department)
Non-Surgical / Conservative Management
*Indicated for stable, non-sustained VT, idiopathic VT, or as bridge/adjunct to ablation.*
- •Antiarrhythmic Medications (Oral):
- *Sotalol*: ¥90–¥260/month ($13–$37) - *Mexiletine*: ¥60–¥180/month ($9–$26)
- •Baseline Diagnostic Workup (mandatory before initiation):
- Echocardiogram (TTE): ¥480 ($68) - Serum electrolytes, troponin, TSH, liver/kidney function: ¥290 ($41)
- •Monitoring Costs:
- Annual echocardiogram: ¥480 ($68)
Surgical / Procedural / Interventional Options
*Eligibility: Sustained VT, ICD shocks, structural heart disease (e.g., prior MI, cardiomyopathy), or drug-refractory idiopathic VT.*
- •Catheter Ablation (Radiofrequency or Cryo):
- *Procedure fee* (including fluoroscopy, 3D mapping system, ablation catheter): ¥38,000–¥52,000 ($5,380–$7,370) - *Hospital stay* (5–7 days, ICU monitoring if high-risk): ¥12,000–¥18,000 ($1,700–$2,550)
- •Implantable Cardioverter-Defibrillator (ICD):
- *Implantation procedure + hospitalization* (3–5 days): ¥22,000–¥31,000 ($3,120–$4,400)
Special / Complex Condition Management
- •VT Storm (≥3 episodes in 24h):
- IV amiodarone loading + sedation + hemodynamic support: ¥1,600/day ($227) - Urgent ablation (within 48h): +¥8,000 ($1,135) surcharge
- •Post-Infarction VT with LVEF <35%:
- Combined ablation + ICD: ¥135,000–¥168,000 ($19,140–$23,820)
Quick Selection Guide
- •Young, healthy, idiopathic VT (<45 yrs): First-line catheter ablation (¥38,000–¥52,000). Avoid lifelong drugs; cure rate >90%.
- •Elderly (>75 yrs), multiple comorbidities, low ejection fraction: ICD + optimized GDMT, deferring ablation unless recurrent shocks. Budget: ¥87,000–¥143,000.
- •Budget-constrained, stable non-sustained VT: Sotalol + strict follow-up (annual total ~¥2,200, $312); avoid amiodarone due to long-term toxicity monitoring costs.
- •VT storm or recurrent ICD shocks: Urgent ablation + ICU stabilization, regardless of age—cost justified by mortality reduction.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Ventricular tachycardia Medical Vacation Packages
Curated transparent all-inclusive packages combining Ventricular tachycardia treatment with China top medical destinations:
